Search results for " Myocardial infarction"

showing 10 items of 247 documents

Nitric oxide metabolites (nitrite and nitrate) in young patients with recent acute myocardial infarction

2008

Nitric oxide (NO) has a role in the pathophysiology of acute and chronic cardiovascular events. We studied the plasma concentration of NO stable end products (nitrite and nitrate - NO x ) in 43 patients aged <46 years, with recent acute myocardial infarction (AMI). The evaluation was effected at the initial stage, after 3 and 12 months. We subdivided the patients into subgroups according to the number of the main cardiovascular risk factors and to the extent of coronary disease. In the whole group the NO x concentration was initially increased and progressively decreased after 3 and 12 months, remaining at both times significantly higher than in control subjects. The patients with more risk…

AdultMalecardiovascular risk factorsmedicine.medical_specialtyPhysiologyCardiovascular risk factorsMyocardial Infarctionacute myocardial infarctionNitric oxidechemistry.chemical_compoundNitrateRisk FactorsnitratePhysiology (medical)Internal medicinemedicineHumansMyocardial infarctionNitritenitriteNitritesInflammationNitratesbusiness.industryNitric oxideHematologymedicine.diseaseControl subjectsPathophysiologychemistryPlasma concentrationCardiologyFemaleCardiology and Cardiovascular MedicinebusinessClinical Hemorheology and Microcirculation
researchProduct

Analysis of the Blood Viscosity Behavior in the Sicilian Study on Juvenile Myocardial Infarction

2018

Considering the role of hemorheology in coronary circulation, we studied blood viscosity in patients with juvenile myocardial infarction. We examined whole blood viscosity at high shear rate using the cone-on-plate viscosimeter Wells-Brookfield ½ LVT and at low shear rate employing a viscometer Contraves LS30 in 120 patients (aged &lt;46 years) with myocardial infarction, at the initial stage and subsequently 3 and 12 months after. At the initial stage, patients had an increased whole blood viscosity in comparison to normal controls. This hemorheological profile was not influenced by the cardiovascular risk factors, nor by the extent of coronary lesions, even if some differences were evide…

AdultMalemedicine.medical_specialtyAcute coronary syndromeBlood viscosityInfarction030204 cardiovascular system & hematologyFollow-Up Studie03 medical and health sciencesCoronary circulation0302 clinical medicineInternal medicinemedicineHumanscardiovascular diseases030212 general & internal medicineMyocardial infarctionAcute Coronary SyndromeNeutrophil to lymphocyte ratioblood rheologybusiness.industryOriginal ArticlesHematologyGeneral MedicineMiddle AgedBlood Viscositymedicine.diseasemedicine.anatomical_structureItalyHeart failureCardiologyST Elevation Myocardial InfarctionFemaleHemorheologyjuvenile myocardial infarctionbusinessFollow-Up StudiesHumanClinical and Applied Thrombosis/Hemostasis
researchProduct

Serum uric acid and fatal myocardial infarction: Detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study

2019

Supplemental Digital Content is available in the text

AdultMalemedicine.medical_specialtyAdolescentPhysiologycut-off value030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicineuric acidInternal medicineInternal MedicinemedicineORIGINAL PAPERS: EpidemiologyHumanssex030212 general & internal medicineHyperuricemiaMyocardial infarctionRisk factorAgedAged 80 and overuric acid cardiovascular arterial hypertensioncut-off value mortality myocardial infarctionsex uric acidProportional hazards modelbusiness.industrycut-off value mortality myocardial infarction sex uric acidHazard ratioMiddle Agedmedicine.diseasePrognosismortalityConfidence intervalUric acid myocardial infarction epidemiologymyocardial infarctionchemistryItalyHypertensionComputingMethodologies_DOCUMENTANDTEXTPROCESSINGcut-off value; mortality; myocardial infarction; sex; uric acidUric acidFemaleCardiology and Cardiovascular MedicinebusinessCohort study
researchProduct

ST2 and left ventricular remodeling after ST-segment elevation myocardial infarction: A cardiac magnetic resonance study.

2018

Background: The association of soluble interleukin-1 receptor-like 1 (ST2) with left ventricular (LV) remodeling is unclear in patients with a first ST-segment elevation myocardial infarction (STEMI). The objective of this work was to assess the relationship between ST2, a marker of inflammation, and cardiac magnetic resonance (CMR) imaging-derived LV remodeling after a first STEMI. Methods: We prospectively evaluated 109 patients with a first STEMI treated with primary percutaneous coronary intervention who had ST2 assessed 24 h post-reperfusion. All patients underwent CMR imaging 1 week and 6 months after STEMI. The independent associations between ST2, LV diastolic and systolic volume in…

AdultMalemedicine.medical_specialtyCardiac magnetic resonancemedicine.medical_treatmentDiastoleMagnetic Resonance Imaging Cine030204 cardiovascular system & hematologyCohort Studies03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicineInternal medicinemedicineHumansST segmentProspective Studiescardiovascular diseases030212 general & internal medicineMyocardial infarctionVentricular remodelingEnd-systolic volumeAgedEjection fractionVentricular Remodelingbusiness.industryLeft ventricular remodelingPercutaneous coronary interventionMiddle AgedST2medicine.diseaseInterleukin-1 Receptor-Like 1 ProteinST-segment elevation myocardial infarctioncardiovascular systemCardiologyST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessCardiac magnetic resonanceBiomarkersFollow-Up Studies
researchProduct

Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011:current status in 37 ESC countries

2014

Item does not contain fulltext AIMS: Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. METHODS AND RESULTS: A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, dat…

AdultMalemedicine.medical_specialtyCross-sectional studymedicine.medical_treatmentVascular damage Radboud Institute for Health Sciences [Radboudumc 16]PopulationCardiologyMyocardial Infarctionacute myocardial infarction610 Medicine & healthMyocardial ReperfusionPercutaneous Coronary InterventionReperfusion therapyHumansMedicineThrombolytic TherapyIn patientHospital MortalityRegistriescardiovascular diseasesMyocardial infarctioneducationAgededucation.field_of_studybusiness.industryST elevationCoronary Care UnitsPercutaneous coronary interventionThrombolysisMiddle Agedmedicine.disease3. Good healthEuropeCross-Sectional Studiessurgical procedures operativeEmergency medicineWorkforceFemaleHuman medicineMedical emergencyCardiology and Cardiovascular Medicinebusiness
researchProduct

Left ventricular function after acute myocardial infarction

1976

10 patients with their first AMI were studied within the first 48 hours and again after 3 weeks. Central and peripheral haemodynamics (CI, SV, SW, TPR) were examined, including indices of contractility (dp/dtmax) and wall stiffness (deltaP/deltaV, relation deltaP/deltaV to P) of the left ventricle. In the early phase CI and SW, as well as LV dp/dtmax were depressed in accordance with symptoms of LV failure. deltaP/deltaV was increased. Elevation of LVEDP correlated well with ventricular gallop rhythm, but less consistently with LV functional disturbance. During convalescence CI increased uniformly, both in digitalized and non-digitalized individuals. In contrast heart rate, aortic pressure,…

AdultMalemedicine.medical_specialtyHeart VentriclesMyocardial InfarctionHemodynamicsCritical Care and Intensive Care MedicineContractilityInternal medicineHeart ratemedicineHumansMyocardial infarctionAgedbusiness.industryHemodynamicsElectrocardiography in myocardial infarctionConvalescenceGeneral MedicineMiddle Agedmedicine.diseasePreloadmedicine.anatomical_structureVentricleAcute DiseaseCardiologyAortic pressureFemalebusinessEuropean Journal of Intensive Care Medicine
researchProduct

Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction.

2007

. Objective.  Resistin is an adipokine that has been suggested to be correlated with markers of inflammation and to be predictive of coronary atherosclerosis and type II diabetes in humans. A common single nucleotide polymorphism (SNP) (−420C/G) in the promoter of resistin is associated with increased resistin plasma levels and susceptibility to type II diabetes. The aim of this study was to investigate the association of the -420C/G polymorphism with metabolic syndrome, obesity, myocardial infarction and kidney disease. Design and results.  First we studied 1542 subjects from the PLIC study (a population based cohort). GG carriers showed an higher prevalence of obesity and metabolic syndro…

AdultMalemedicine.medical_specialtyHeart diseaseGenotypeMyocardial InfarctionAdipokineGene ExpressionSingle-nucleotide polymorphismPolymorphism Single NucleotideCohort StudiesInternal medicineInternal MedicinemedicineHumansGenetic Predisposition to DiseaseResistinMyocardial infarctionObesityRNA MessengerPromoter Regions GeneticAgedMetabolic SyndromeFramingham Risk Scorebusiness.industryMiddle Agedmedicine.diseaseLipidsEndocrinologyKidney dysfunction metabolic syndrome myocardial infarction PBMC resistins SNPChronic DiseaseResistinFemaleKidney DiseasesMetabolic syndromebusinessKidney diseaseJournal of internal medicine
researchProduct

Coronary embolism in a young patient with nonbacterial thrombotic endocarditis related to antiphospholipid syndrome

2020

myocardial infarction

AdultMalemedicine.medical_specialtyMEDLINEMagnetic Resonance Imaging CineCoronary AngiographyNonbacterial thrombotic endocarditisAntiphospholipid syndromeInternal medicinemedicineHumansAngioplasty Balloon Coronarycoronary embolismHeart Valve Prosthesis Implantationbusiness.industryGeneral MedicineAntiphospholipid SyndromeCoronary embolismmedicine.diseaseAortic Valve DiseaseTreatment OutcomeCoronary OcclusionEndocarditis Non-InfectiveCardiologyST Elevation Myocardial InfarctionCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealTomography Optical Coherence
researchProduct

Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction

2002

In summary, LDL peak particle size variations occur very early after AMI, and therefore this parameter, which may be considered a genetically determined risk factor, must be measured not before 2 to 3 months after the acute event.

AdultMalemedicine.medical_specialtyMyocardial Infarctionchemistry.chemical_compoundInternal medicineBlood plasmaPlasma lipidsmedicineHumansMyocardial infarctionLow-Density Lipoprotein Acute Myocardial InfarctionRisk factorAgedAged 80 and overbusiness.industryCholesterolCholesterol HDLCholesterol LDLMiddle Agedmedicine.diseaseLipidsCoronary heart diseaseEndocrinologychemistryLow-density lipoproteinCardiologyParticle sizeCardiology and Cardiovascular MedicinebusinessThe American Journal of Cardiology
researchProduct

Behaviour of carbonyl groups in several clinical conditions: Analysis of our survey

2019

Protein carbonylation is a marker of oxidative protein damage, that is likely involved in the pathogenesis of several diseases. The aim of this study was to evaluate the protein carbonyl (PC) groups in different clinical conditions. It included different groups of subjects: 81 trained subjects; 23 subjects with mild essential hypertension; 31 middle-aged subjects with metabolic syndrome (MS); 106 subjects with MS not selected for age (subdivided into two subgroups, with and without diabetes mellitus); 91 obese adults subdivided in two subgroups (BMI 30-35 Kg/m2 and BMI &gt; 35 kg/m2); 48 subjects with obstructive sleep apnea syndrome (OSAS) subdivided in accordance with the apnea/hypopnea i…

AdultMalemedicine.medical_specialtyOxidative stress arterial hypertension metabolic syndrome juvenile myocardial infarction chronic kidney failurePhysiologymedicine.medical_treatment030204 cardiovascular system & hematologyEssential hypertension030218 nuclear medicine & medical imagingProtein Carbonylation03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesPhysiology (medical)Internal medicineDiabetes mellitusmedicineHumansDiseaseMyocardial infarctionDialysisbusiness.industryHematologymedicine.diseaseObstructive sleep apneaFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessOxidation-ReductionHypopneaBiomarkersKidney diseaseClinical Hemorheology and Microcirculation
researchProduct